STAHLBERG JAN bought DMAC
August 25, 2025 · Form 4 insider transaction
STAHLBERG JAN bought 338,265 shares of DiaMedica Therapeutics Inc. at $6.00 per share, a transaction worth $2.03M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 10 days after the transaction.
Direction
Acquired (buy-side)
Shares
338,265
Price
$6.00
Total value
$2.03M
InsiderSTAHLBERG JAN
Role—
SecurityCommon Shares
Transaction codeP: Open-market purchase
Transaction dateAugust 25, 2025
Filing dateSeptember 4, 2025
Shares owned after7,654,045
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares.